Morris Animal Foundation Announces Partnership With the Cornell Veterinary Biobank

Morris Animal Foundation and the Cornell Veterinary Biobank will partner to improve access and provide additional quality control of biological samples collected as part of the Golden Retriever Lifetime Study.

“The partnership with Cornell University ensures our samples meet the highest quality standards for use in groundbreaking scientific studies that benefit dog health,” said Dr. Julia Labadie, Principal Investigator, Golden Retriever Lifetime Study.

The Cornell Veterinary Biobank, a premier animal biobank and the first to achieve ISO 20387 accreditation, a rigorous international standard for biobanking operations. The Cornell team will provide expert biobanking services critical to the success of the Study and the research community at large.

The Golden Retriever Lifetime Study is an innovative initiative composed of owner- and veterinarian-reported data and annual biological samples from a cohort of privately owned dogs living throughout the lower 48 United States.

The Study’s primary objective is to identify the incidence and risk factors for osteosarcoma, hemangiosarcoma, lymphoma and high-grade mast cell tumors. The Foundation is also closely monitoring the incidence of histiocytic sarcoma as it has emerged as a cancer of interest.

Secondary goals include studies of all other cancers and common significant diseases, including hypothyroidism, epilepsy, allergy disorders, hip dysplasia, congestive heart failure and renal failure.

Short URL: https://caninechronicle.com/?p=299270

Posted by Liz on Aug 14 2024. Filed under Current Articles, Featured. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.